SC
VRCA icon

Steven Cohen’s Verrica Pharmaceuticals VRCA Stock Holding History

Steven Cohen’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-337
Closed -$21.9K – 2825
2023
Q1 		$21.9K Buy
+337
New +$20.4K ﹤0.01% 1956
2022
Q4 		– Sell
-48,580
Closed -$1.42M – 1812
2022
Q3 		$1.42M Sell
48,580
-26,815
-36% -$919K 0.01% 1001
2022
Q2 		$1.45M Buy
+75,395
New +$3.79M 0.01% 1008
2019
Q3 		– Sell
-14,221
Closed -$1.65M – 1490
2019
Q2 		$1.65M Sell
14,221
-506
-3% -$47.5K 0.01% 683
2019
Q1 		$1.59M Buy
14,727
+1,722
+13% +$199K 0.01% 736
2018
Q4 		$1.06M Buy
13,005
+4,005
+45% +$486K 0.01% 802
2018
Q3 		$1.46M Buy
+9,000
New +$1.54M 0.01% 802

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steven Cohen's VRCA Position: Q2 2023 in Review

Steven Cohen sold out of Verrica Pharmaceuticals (VRCA) in Q2 2023, closing a stake of 337 shares — an estimated $21.9K sold.

Steven Cohen first reported a position in VRCA in Q3 2018 and held it in 7 quarters. The position peaked at $1.65M in Q2 2019. 63 funds tracked by Wall St. Rank hold VRCA as of Q2 2023.

  • Steven Cohen reported no remaining Verrica Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Steven Cohen sold 337 Verrica Pharmaceuticals shares in Q2 2023, an estimated $21.9K.
  • Steven Cohen first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 7 quarters.
  • Steven Cohen's Verrica Pharmaceuticals position peaked at $1.65M in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.